Literature DB >> 17541018

Regulatory T cells depress immune responses to protective antigens in active tuberculosis.

Jean-Michel Hougardy1, Sammy Place, Marc Hildebrand, Annie Drowart, Anne-Sophie Debrie, Camille Locht, Francoise Mascart.   

Abstract

RATIONALE: Tuberculosis (TB) remains a leading cause of death, and the role of T-cell responses to control Mycobacterium tuberculosis infections is well recognized. Patients with latent TB infection develop strong IFN-gamma responses to the protective antigen heparin-binding hemagglutinin (HBHA), whereas patients with active TB do not.
OBJECTIVES: We investigated the mechanism of this difference and evaluated the possible involvement of regulatory T (Treg) cells and/or cytokines in the low HBHA T-cell responses of patients with active TB.
METHODS: The impact of anti-transforming growth factor (TGF)-beta and anti-IL-10 antibodies and of Treg cell depletion on the HBHA-induced IFN-gamma secretion was analyzed, and the Treg cell phenotype was characterized by flow cytometry.
MEASUREMENTS AND MAIN RESULTS: Although the addition of anti-TGF-beta or anti-IL-10 antibodies had no effect on the HBHA-induced IFN-gamma secretion in patients with active TB, depletion of CD4(+)CD25(high)FOXP3(+) T lymphocytes resulted in the induction by HBHA of IFN-gamma concentrations that reached levels similar to those obtained for latent TB infection. No effect was noted on the early-secreted antigen target-6 or candidin T-cell responses.
CONCLUSIONS: Specific CD4(+)CD25(high)FOXP3(+) T cells depress the T-cell-mediated immune responses to the protective mycobacterial antigen HBHA during active TB in humans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17541018     DOI: 10.1164/rccm.200701-084OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  72 in total

1.  Human lung immunity against Mycobacterium tuberculosis: insights into pathogenesis and protection.

Authors:  Stephan Schwander; Keertan Dheda
Journal:  Am J Respir Crit Care Med       Date:  2010-11-12       Impact factor: 21.405

2.  Imbalance of Th17 cells and regulatory T cells in tuberculous pleural effusion.

Authors:  Zhi-Jian Ye; Qiong Zhou; Rong-Hui Du; Xiao Li; Bo Huang; Huan-Zhong Shi
Journal:  Clin Vaccine Immunol       Date:  2011-08-03

Review 3.  T regulatory cells: Achilles' heel of Mycobacterium tuberculosis infection?

Authors:  Om Parkash; Sonali Agrawal; M Madhan Kumar
Journal:  Immunol Res       Date:  2015-07       Impact factor: 2.829

4.  Safety and reactogenicity of BCG revaccination with isoniazid pretreatment in TST positive adults.

Authors:  Mark Hatherill; Hendrik Geldenhuys; Bernadette Pienaar; Sara Suliman; Phalkun Chheng; Sara M Debanne; Daniel F Hoft; W Henry Boom; Willem A Hanekom; John L Johnson
Journal:  Vaccine       Date:  2014-05-09       Impact factor: 3.641

Review 5.  The paradoxical effects of vitamin D on type 1 mediated immunity.

Authors:  Margherita T Cantorna; Sanhong Yu; Danny Bruce
Journal:  Mol Aspects Med       Date:  2008-05-04

6.  Tuberculous pleurisy drives marked effector responses of γδ, CD4+, and CD8+ T cell subpopulations in humans.

Authors:  Jincheng Zeng; Zeqing Song; Xiaozhen Cai; Su Huang; Wandang Wang; Yanfen Zhu; Yinan Huang; Bin Kong; Wenyu Xiang; Dongzi Lin; Ganbin Liu; Junai Zhang; Crystal Y Chen; Hongbo Shen; Dan Huang; Ling Shen; Lailong Yi; Junfa Xu; Zheng W Chen
Journal:  J Leukoc Biol       Date:  2015-07-08       Impact factor: 4.962

7.  Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity.

Authors:  Simone A Joosten; Krista E van Meijgaarden; Pascale C van Weeren; Fatima Kazi; Annemieke Geluk; Nigel D L Savage; Jan W Drijfhout; Darren R Flower; Willem A Hanekom; Michèl R Klein; Tom H M Ottenhoff
Journal:  PLoS Pathog       Date:  2010-02-26       Impact factor: 6.823

8.  FOXP3 expression is upregulated in CD4T cells in progressive HIV-1 infection and is a marker of disease severity.

Authors:  Melinda S Suchard; Elizabeth Mayne; Victoria A Green; Sharon Shalekoff; Samantha L Donninger; Wendy S Stevens; Clive M Gray; Caroline T Tiemessen
Journal:  PLoS One       Date:  2010-07-23       Impact factor: 3.240

9.  Expansion of pathogen-specific T-helper 1 and T-helper 17 cells in pulmonary tuberculosis with coincident type 2 diabetes mellitus.

Authors:  Nathella Pavan Kumar; Rathinam Sridhar; Vaithilingam V Banurekha; Mohideen S Jawahar; Thomas B Nutman; Subash Babu
Journal:  J Infect Dis       Date:  2013-05-28       Impact factor: 5.226

10.  Immunomodulation with recombinant interferon-gamma1b in pulmonary tuberculosis.

Authors:  Rod Dawson; Rany Condos; Doris Tse; Maryann L Huie; Stanley Ress; Chi-Hong Tseng; Clint Brauns; Michael Weiden; Yoshihiko Hoshino; Eric Bateman; William N Rom
Journal:  PLoS One       Date:  2009-09-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.